GILEAD SCIENCES, INC. Derivative Liability, Fair Value, Gross Liability
GILEAD SCIENCES, INC. (GILD) had Derivative Liability, Fair Value, Gross Liability of $5.00 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Offsetting › Offsetting Derivative Liabilities › Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2022-02-23
- 2021-12-31: Derivative Liability, Fair Value, Gross Liability $5.00M.
- 2021-09-30: Derivative Liability, Fair Value, Gross Liability $8.00M.
- 2021-06-30: Derivative Liability, Fair Value, Gross Liability $30.00M.
- 2021-03-31: Derivative Liability, Fair Value, Gross Liability $41.00M.
| Period end | Derivative Liability, Fair Value, Gross Liability | Derivative Liability, Fair Value, Gross Liability as first filed |
|---|---|---|
| 2021-12-31 | $5.00M 10-K · filed 2022-02-23 | |
| 2021-09-30 | $8.00M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $30.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $41.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $121.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $50.00M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $18.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $5.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $8.00M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $6.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.00M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $6.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $11.00M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $110.00M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $93.00M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $101.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $55.00M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $17.00M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $37.00M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $162.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $193.00M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $140.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $41.00M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $35.00M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $39.00M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $9.00M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $0.00 10-K · filed 2016-02-24 | |
| 2014-09-30 | $3.70M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $40.47M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $72.37M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $99.00M 10-K · filed 2015-02-25 | $99.06M 10-K · filed 2014-02-25 |
| 2013-09-30 | $61.11M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $13.88M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $18.67M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $65.25M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $34.13M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $4.09M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $18.40M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $5.71M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $39.12M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $140.34M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $118.08M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $38.55M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $58.78M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $10.02M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $47.69M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |